FDA issues 'Class I' recall of unauthorized E25Bio rapid Covid tests

The Food and Drug Administration (FDA) has issues a Class I recall of the E25Bio rapid COVID-19 test, a product being sold without authorization from the agency.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States , ,Drug Administration ,Antigen Response Tests ,Antigen Rapid Test ,Dailymail ,Health ,Fda ,Coronavirus ,